HRSA-25-020: Maternal and Child Health Research Consortium (MCH RC)
Closed
This grant is closed. A newer notice from the same program is open now: Women's Initiative for Screening and Health (WISH) (HRSA-27-072). Status: Closes January 8, 2027 (62 days left). It is in our archive of Health Resources and Services Administration notices from 2025.
Health Resources and Services Administration offered grants to nonprofits, state and local governments and tribes. It expected to make about 3 awards worth $1.8 million in total. Applications closed on April 23, 2025.
From the official notice on Grants.gov, last changed January 17, 2025. Checked November 7, 2026.
- Total funding$1.8 million
- Expected awards3
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | January 17, 2025 |
|---|---|
| Deadline | April 23, 2025 |
Who can apply
This opportunity was open to nonprofits, state and local governments and tribes.
All 10 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
These types of domestic organizations (who are otherwise eligible as per the criteria above) may apply. Domestic means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Public institutions of higher education Non-profit institutions of higher education Private non-profit entities State, county, city, township, and special district governments, including the District of Columbia, domestic territories, and freely associated states Independent school districts Native American tribal governments Native American tribal organizations
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Maternal and Child Health Bureau Research Consortium Program (MCHB RCP) creates a national group of researchers to study maternal and child health (MCH). In the past, MCHB funded research networks, single investigator innovation studies, and field-initiated research studies. The MCHB RCP merges these programs into one. In FY 2025, this NOFO replaces the Research Network Program; including the Pregnancy-Related Care Research Network (PRCRN) and Pediatric Research in Office Settings (PROS). MCH RC recipients will develop research-practice partnerships[4] with community organizations, people and families with lived experience,[5] and MCHB programs such as Healthy Start, Maternal, Infant, and Early Childhood Home Visiting (MIECHV), and Title V programs. Through these partnerships, you will identify best practices for maximizing the impact of your research. You are expected to focus on one of the following categories. You can focus on one or more of the priority topics listed within each category:
Who has won Special Projects of Regional and National Significance grants before
From fiscal 2021 to 2025, Special Projects of Regional and National Significance (93.110) awarded $1.4 billion across 842 grant awards, an average of $1.6 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Zero to Three National Center for Infants, Toddlers & Families | District of Columbia | 2 | $54.3 million |
| University Hospitals Cleveland Medical Center | Ohio | 1 | $51.5 million |
| Children's National Medical Center | District of Columbia | 1 | $37.2 million |
| University of North Carolina at Chapel Hill | North Carolina | 8 | $29.1 million |
| American Academy of Pediatrics | Illinois | 8 | $26.4 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-072, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-020 still open?
No. It closed on April 23, 2025. A newer notice is open: HRSA-27-072, closes January 8, 2027 (62 days left).
Who can apply for Maternal and Child Health Research Consortium (MCH RC)?
Health Resources and Services Administration accepted applications from nonprofits, state and local governments and tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Maternal and Child Health Research Consortium (MCH RC)?
Closed April 23, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $1.8 million in total across about 3 awards.
Who has won Special Projects of Regional and National Significance grants before?
The largest recipients over five fiscal years were Zero to Three National Center for Infants, Toddlers & Families, University Hospitals Cleveland Medical Center, Children's National Medical Center. The program made 842 awards worth $1.4 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)